Ronan Kelly, MD

Articles by Ronan Kelly, MD

LAG-3 and PD-1 Inhibitors for Esophageal and Gastroesophageal Junction Cancer: A Phase Ib Trial

Ronan Kelly, MDGastroesophageal Cancer | March 13, 2025

Dr. Ronan Kelly describes his trial on nivolumab with relatlimab for the treatment of resectable esophageal/GEJ cancer.